Tatva Chintan Pharma Chem Ltd.

₹1,678.5

82.3 (5.2%)

TATVA Share Price

Chemicals & Petrochemicals

As on September 4, 2026

SectorChemicals

IndustryChemicals & Petrochemicals

Basic IndustrySpecialty Chemicals

Market Cap₹ 3,923 Cr

P/E Ratio93.36

Dividend Yield0.01 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,624.66	Bullish
10-DMA	1,614.54	Bullish
20-DMA	1,656.17	Bullish
50-DMA	1,568.48	Bullish
100-DMA	1,403.52	Bullish
200-DMA	1,339.48	Bullish

Historical Performance

1 Year

61.9%

3 Years

-3.5%

5 Years

-18.1%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	5,059	3,827	3,935	4,236	4,336
Total Expenditure	4,124	3,483	3,251	3,628	3,251
Other Income	35	23	75	57	90
Operating Profit	970	368	759	665	1,175
Interest	31	15	67	86	52
Depreciation	368	277	256	96	82
Profit Before Tax	570	76	436	448	1,041
Consolidated Net Profit	421	57	304	455	959
Adjusted EPS	18	2	13	21	43

Compounded Sales Growth

10 Years:30.1

5 Years:11

3 Years:3.6

TTM:5.7

Compounded Profit Growth

10 Years:26.5

5 Years:-4.3

3 Years:-1.6

TTM:49.1

Stock Price CAGR

10 Years:N/A

5 Years:-3.8

3 Years:0.5

TTM:68.3

Return on Equity

10 Years:N/A

5 Years:43.3

3 Years:13

last year:18

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	234	234	234	222	222
Total Reserves	7,584	7,154	7,137	4,926	4,509
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	-8	-112	-103	-110	51
Other Current Liabilities	397	251	242	497	330
Short Term Borrowings	1,143	357	100	1,562	925
Total Liabilities	9,941	8,237	8,065	7,443	6,493
Capital Work in Progress	233	215	729	2,307	515
Long Term Loans & Advances	46	43	43	27	21
Currents Investments	---	---	101	---	---
Short Term Loans and Advances	176	213	203	173	267
Total Current Assets	3,495	2,653	2,980	3,141	4,356
Total Assets	9,941	8,237	8,065	7,443	6,493
Adjusted Book Value	334	316	315	232	213

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 93.36, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of 0.5%, indicating poor shareholder returns.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹970 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹5059 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1709092.8

No. of Shares: 1018 (Approx)

Performance:70.9%

709092.8

NIFTY Performance: -3.4%

1 day Top Gainers